Impetigo: etiology and therapy
Clicks: 495
ID: 112610
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
77.5
/100
495 views
321 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 2 articles by views in current clinical topics in infectious diseases
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Impetigo: etiology and therapy
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (4 words).
Try re-searching for a better abstract.
| Reference Key |
jv2002currentimpetigo:
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hirschmann JV;; |
| Journal | current clinical topics in infectious diseases |
| Year | 2002 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adolescent
Child
Skin Diseases
preschool
anti-bacterial agents / therapeutic use
impetigo / drug therapy*
prevalence
pmid:12520646
j v hirschmann
anti-bacterial agents / classification
dermatitis / microbiology
dermatitis / prevention & control
impetigo / diagnosis
impetigo / epidemiology
impetigo / microbiology*
vesiculobullous / epidemiology
vesiculobullous / microbiology
vesiculobullous / pathology
staphylococcus aureus / pathogenicity
streptococcus pyogenes / pathogenicity
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.